The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships. PharmGKB collects and disseminates knowledge about the impact of human genetic variation on drug responses; curates and displays primary genotype and phenotype data; annotates gene variants and gene-drug-disease relationships via literature reviews; summarizes important pharmacogenomic genes and drug pathways; and enables consortia examining important questions in pharmacogenomics. PharmGKB is funded by NIH/NHGRI/NICHD (U24 HG010615).
| Website | http://www.pharmgkb.org |
| Revenue | $7.9 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2000 |
| Phone | +1 650-725-0659 |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Web Rank | 374923 |
| Web Visits | 95820 |
| Keywords | Pharmacogenomics, Pharmacogenetics, Clinical Information, Precision Medicine, Clinical Decision Support, Personalized Medicine, Clinical Research, Drug Response, Genetic Testing, Healthcare Data, Drug Interactions, Therapeutics, Drug Development, Bioinformatics |
| Competitors | Thermo Fisher Scientific, Illumina, Natera, Myriad Genetics, Foundation Medicine, Invitae, 23andMe, Genomics England, Medicinal Genomics, Clinical Pharmacogenetics Implementation Consortium +40 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular PharmGKB employee's phone or email?
PharmGKB Questions
The PharmGKB annual revenue was $7.9 million in 2026.
PharmGKB is based in Stanford, California.
The NAICS codes for PharmGKB are [5417, 541713, 541, 54, 54171].
The SIC codes for PharmGKB are [873, 87].
Related Companies
